Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants
Journal of the Endocrine Society · 03.06.2026 · 10 (7)
DOI: 10.1210/jendso/bvag128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 05.06.2026. Verfasst von Anum und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Section of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine and the Center for Human Nutrition, UT So…. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Context
Specific heterozygous pathogenic variants in LMNA have been reported in patients with Dunnigan-type familial partial lipodystrophy (FPLD2), while other variants cause autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD). FPLD2 is characterized by variable loss of subcutaneous fat from the extremities and trunk, and AD-EDMD is characterized by early joint contractures, proximal muscle weakness, and cardiac conduction defects. Previously, only 2 families have been reported with combined features of FPLD2 and AD-EDMD.
Objective
To report the overlapping phenotype of both FPLD2 and AD-EDMD in 5 families with heterozygous LMNA variants.
Methods
Clinical, anthropometric, laboratory, and genotyping data of affected subjects from 5 families with female probands presenting with FPLD2 and AD-EDMD phenotypes were collected.
Results
Affected individuals (8 females, ages 18-57 years; 3 males, ages 25-41 years) harbored heterozygous p.T528R, p.R527P, p.R541P, or p.R453W LMNA variants. Five females and 2 males had joint contractures and proximal muscle weakness, and 4 females and 1 male had pacemaker-defibrillator implantation for cardiac arrhythmias, confirming AD-EDMD. Subcutaneous fat loss from the extremities confirming FPLD2 was observed in all females but only in 2 males. Four females had diabetes mellitus and hypertriglyceridemia, and 1 male had hypertriglyceridemia. Two females, 50 and 58 years old, died due to aspiration pneumonia and cerebrovascular accident, respectively, and one 40-year-old male died of alcoholic liver disease.
Conclusion
Our report brings attention to the frequent co-occurrence of FPLD2 and AD-EDMD. In the future, all patients with AD-EDMD should be carefully evaluated for clinical signs of lipodystrophy and metabolic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Section of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine and the Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX 75390-8537, USA.
- Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX 75390-9066, USA.
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Anum, Abhimanyu Garg
Förderung
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Anum, Li, X., Brown, R. J., & Garg, A. (2026). Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag128
Vancouver
Anum, Li X, Brown RJ, Garg A. Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag128
BibTeX
@article{Anum2026,
author = {Anum and Li, Xilong and Brown, Rebecca J and Garg, Abhimanyu},
title = {Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {7},
doi = {10.1210/jendso/bvag128}
}
EUVIMED